Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties (Q44835411)
Jump to navigation
Jump to search
scientific article published in May 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties |
scientific article published in May 2004 |
Statements
1 reference
Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties (English)
1 reference
Sho-ichi Yamagishi
1 reference
Yosuke Inagaki
1 reference
Kazuo Nakamura
1 reference
Tsutomu Imaizumi
1 reference
1 reference
Identifiers
1 reference